Dr Morse is a Associate Visiting Surgeon in the Dept of Surgery and an Assistant Professor of Surgery at Harvard Medical School. He serves as the Co-Director of the Gastroesophageal Surgery Program.
BiographyDr Morse graduated from Columbia University College of Physicians and Surgeons. He did both his surgical residencies at the MGH, first in general surgery and then in Cardiothoracic Surgery. Dr. Morse went on complete a second fellowship in minimally invasive thoracic surgery with a particular emphasis on esophageal surgery. He is Board certified in both Surgery and Thoracic Surgery.
Dr Morse is clinically very active and sees new patients weekly. His clinical interests revolve around malignancies of the chest, especially lung and esophageal cancer, as well as the treatment a variety of benign esophageal conditions, including achalasia, paraesophageal hernia and gastroesophageal reflux disease. Dr. Morse has taken a lead role in the development of a minimally invasive esophagectomy program at MGH. This work has led to a number of manuscripts including a direct comparison of open vs. minimally invasive esophagectomy.
Dr. Morse serves as the co-director of the MGH Gastroesophageal Surgery program and participates on workforces in several national thoracic societies.
Christopher Morse, MD, reviews minimally invasive treatments for esophageal cancer, including esophageal resections. Please note that this video contains images from a real procedure and may cause discomfort for some viewers.
Minimally invasive esophagectomy (MIE) is a procedure performed by Massachusetts General Hospital surgeons using small incisions to remove a diseased esophagus and reconstruct the gastrointestinal tract. For more information, visit massgeneral.org/MIE
Christopher Morse, MD, of the Division of Thoracic Surgery at Massachusetts General Hospital has been able to remove esophageal tumors using an innovative minimally invasive procedure that offers patients less postoperative pain and a shorter recovery time
Bob Hazelton lived with chronic acid reflux for years and was diagnosed with esophageal cancer in 2011. After his surgical team at Massachusetts General Hospital performed a minimally invasive esophagectomy, Bob has a healthy esophagus and is getting back to his active lifestyle.